bioluminescence imaging allows monitoring hepatitis c virus core protein inhibitors in mice生物荧光成像允许监控丙型肝炎病毒核心蛋白抑制剂在老鼠身上.pdfVIP

Bioluminescence Imaging Allows Monitoring Hepatitis C Virus Core Protein Inhibitors in Mice 1. 1. 1 1 2 1 1 Juan Du , Fang Zhao , Yong Zhou , Hu Yan , Xiang-guo Duan , Sheng-qiang Liang , Ying-li Wang , 1 1 1 1 Qiu-xia Fu , Xiao-hui Wang , Jian-chun Peng , Lin-sheng Zhan * 1 Beijing Institute of Transfusion Medicine, Beijing, China, 2 Ningxia Medical University, Yinchuan, China Abstract Background: The development of small molecule inhibitors of hepatitis C virus (HCV) core protein as antiviral agents has been intensively pursued as a viable strategy to eradicate HCV infection. However, lack of a robust and convenient small animal model has hampered the assessment of in vivo efficacy of any antiviral compound. Methodology/Principal Findings: The objective of this work was to develop a novel method to screen anti-core protein siRNA in the mouse liver by bioluminescence imaging. The inhibitory effect of two shRNAs targeting the highly conserved core region of the HCV genome, shRNA452 and shRNA523, was examined using this method. In the transient mouse model, the effect of shRNA-523 was detectable at as early as 24 h and became even more pronounced at later time points. The effect of shRNA-452 was not detectable until 48 h post-transduction. In a stable mouse model, shRNA523 reduced luciferase levels by up to 76.4626.0% and 91.868.0% at 6 h and 12 h after injection respectively, and the inhibitory effect persisted for 1 day after a single injection while shRNA-Scramble did not seem to have an effect on the luciferase activity in vivo. Conclusions/Significance: Thus, we developed a simple and quantitative assay for real-time monitori